APO Research
Talk to an analyst

APO RESEARCH · REPORT

Nucleic Acid Nanotechnology

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Nucleic Acid Nanotechnology Market Analysis and Forecast 2026-2032

5 June 2026189 pages

Choose your research edition.

Industry ResearchNucleic Acid Nanotechnology Industry Research Report 2026124 pages · $2,950 USDIndustry Growth & TrendsGlobal Nucleic Acid Nanotechnology Industry Growth and Trends Forecast to 2032104 pages · $3,450 USDMarket StructureGlobal Nucleic Acid Nanotechnology Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032198 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Nucleic Acid Nanotechnology Market Outlook and Growth Opportunities 2026198 pages · $4,250 USDMarket Analysis & ForecastGlobal Nucleic Acid Nanotechnology Market Analysis and Forecast 2026-2032189 pages · $4,950 USD

Market perspective

The global Nucleic Acid Nanotechnology market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The North America market for Nucleic Acid Nanotechnology is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Nucleic Acid Nanotechnology is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Nucleic Acid Nanotechnology is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Nucleic Acid Nanotechnology is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global companies of Nucleic Acid Nanotechnology include GATTAQUANT GMBH, NuProbe, Genisphere, Nanovery, Esya Labs, Nomic,, Torus Biosystems, NanoApps Medical, Inc. and Creative Biolabs, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

Report Includes

This report presents an overview of global market for Nucleic Acid Nanotechnology, market size. Analyses of the global market trends, with historic market revenue data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Nucleic Acid Nanotechnology, also provides the revenue of main regions and countries. Of the upcoming market potential for Nucleic Acid Nanotechnology, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Nucleic Acid Nanotechnology revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Nucleic Acid Nanotechnology market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2021 to 2032. Evaluation and forecast the market size for Nucleic Acid Nanotechnology revenue, projected growth trends, production technology, application and end-user industry.

Nucleic Acid Nanotechnology Segment by Company

GATTAQUANT GMBH

NuProbe

Genisphere

Nanovery

Esya Labs

Nomic,

Torus Biosystems

NanoApps Medical, Inc.

Creative Biolabs

tilibit nanosystems

Nucleic Acid Nanotechnology Segment by Type

DNA Nanotechnology

RNA Nanotechnology

Nucleic Acid Nanotechnology Segment by Application

Drug Delivery Systems

Biosensors

Nanorobotics

Other

Nucleic Acid Nanotechnology Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key players, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Nucleic Acid Nanotechnology market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Nucleic Acid Nanotechnology and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in market size), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Nucleic Acid Nanotechnology.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Revenue of Nucleic Acid Nanotechnology in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 4: Detailed analysis of Nucleic Acid Nanotechnology company competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Nucleic Acid Nanotechnology revenue, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, revenue for each segment.

Chapter 9: Europe by type, by application and by country, revenue for each segment.

Chapter 10: China type, by application, revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, revenue for each segment.

Chapter 13: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Nucleic Acid Nanotechnology Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. DNA Nanotechnology Major Player Table 3. RNA Nanotechnology Major Player Table 4. Global Nucleic Acid Nanotechnology Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 5. Drug Delivery Systems Major Player Table 6. Biosensors Major Player Table 7. Nanorobotics Major Player Table 8. Other Major Player Table 9. Nucleic Acid Nanotechnology Industry Trends Table 10. Nucleic Acid Nanotechnology Industry Drivers Table 11. Nucleic Acid Nanotechnology Industry Opportunities and Challenges Table 12. Nucleic Acid Nanotechnology Industry Restraints Table 13. Global Nucleic Acid Nanotechnology Market Size Growth Rate (CAGR) by Region (US$ Million): 2021 VS 2025 VS 2032 Table 14. Global Nucleic Acid Nanotechnology Market Size by Region (2021-2026) & (US$ Million) Table 15. Global Nucleic Acid Nanotechnology Market Share by Region (2021-2026) Table 16. Global Nucleic Acid Nanotechnology Market Size by Region (2027-2032) & (US$ Million) Table 17. Global Nucleic Acid Nanotechnology Market Share by Region (2027-2032) Table 18. Global Nucleic Acid Nanotechnology Revenue by Players (US$ Million) & (2021-2026) Table 19. Global Nucleic Acid Nanotechnology Revenue Market Share by Players (2021-2026) Table 20. Global Nucleic Acid Nanotechnology Key Players Ranking, 2024 VS 2025 VS 2026 Table 21. Global Nucleic Acid Nanotechnology Key Players Headquarters & Area Served Table 22. Global Nucleic Acid Nanotechnology Players, Product Type & Application Table 23. Global Nucleic Acid Nanotechnology Players Establishment Date Table 24. Global Players Market Concentration Ratio (CR5 and HHI) Table 25. Global Nucleic Acid Nanotechnology by Players Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 26. Global Nucleic Acid Nanotechnology Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 27. Global Nucleic Acid Nanotechnology Revenue by Type (2021-2026) & (US$ Million) Table 28. Global Nucleic Acid Nanotechnology Revenue by Type (2027-2032) & (US$ Million) Table 29. Global Nucleic Acid Nanotechnology Revenue Market Share by Type (2021-2026) Table 30. Global Nucleic Acid Nanotechnology Revenue Market Share by Type (2027-2032) Table 31. Global Nucleic Acid Nanotechnology Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 32. Global Nucleic Acid Nanotechnology Revenue by Application (2021-2026) & (US$ Million) Table 33. Global Nucleic Acid Nanotechnology Revenue by Application (2027-2032) & (US$ Million) Table 34. Global Nucleic Acid Nanotechnology Revenue Market Share by Application (2021-2026) Table 35. Global Nucleic Acid Nanotechnology Revenue Market Share by Application (2027-2032) Table 36. GATTAQUANT GMBH Company Information Table 37. GATTAQUANT GMBH Business Overview Table 38. GATTAQUANT GMBH Nucleic Acid Nanotechnology Revenue and Gross Margin (US$ Million) & (2021-2026) Table 39. GATTAQUANT GMBH Nucleic Acid Nanotechnology Product Portfolio Table 40. GATTAQUANT GMBH Recent Development Table 41. NuProbe Company Information Table 42. NuProbe Business Overview Table 43. NuProbe Nucleic Acid Nanotechnology Revenue and Gross Margin (US$ Million) & (2021-2026) Table 44. NuProbe Nucleic Acid Nanotechnology Product Portfolio Table 45. NuProbe Recent Development Table 46. Genisphere Company Information Table 47. Genisphere Business Overview Table 48. Genisphere Nucleic Acid Nanotechnology Revenue and Gross Margin (US$ Million) & (2021-2026) Table 49. Genisphere Nucleic Acid Nanotechnology Product Portfolio Table 50. Genisphere Recent Development Table 51. Nanovery Company Information Table 52. Nanovery Business Overview Table 53. Nanovery Nucleic Acid Nanotechnology Revenue and Gross Margin (US$ Million) & (2021-2026) Table 54. Nanovery Nucleic Acid Nanotechnology Product Portfolio Table 55. Nanovery Recent Development Table 56. Esya Labs Company Information Table 57. Esya Labs Business Overview Table 58. Esya Labs Nucleic Acid Nanotechnology Revenue and Gross Margin (US$ Million) & (2021-2026) Table 59. Esya Labs Nucleic Acid Nanotechnology Product Portfolio Table 60. Esya Labs Recent Development Table 61. Nomic, Company Information Table 62. Nomic, Business Overview Table 63. Nomic, Nucleic Acid Nanotechnology Revenue and Gross Margin (US$ Million) & (2021-2026) Table 64. Nomic, Nucleic Acid Nanotechnology Product Portfolio Table 65. Nomic, Recent Development Table 66. Torus Biosystems Company Information Table 67. Torus Biosystems Business Overview Table 68. Torus Biosystems Nucleic Acid Nanotechnology Revenue and Gross Margin (US$ Million) & (2021-2026) Table 69. Torus Biosystems Nucleic Acid Nanotechnology Product Portfolio Table 70. Torus Biosystems Recent Development Table 71. NanoApps Medical, Inc. Company Information Table 72. NanoApps Medical, Inc. Business Overview Table 73. NanoApps Medical, Inc. Nucleic Acid Nanotechnology Revenue and Gross Margin (US$ Million) & (2021-2026) Table 74. NanoApps Medical, Inc. Nucleic Acid Nanotechnology Product Portfolio Table 75. NanoApps Medical, Inc. Recent Development Table 76. Creative Biolabs Company Information Table 77. Creative Biolabs Business Overview Table 78. Creative Biolabs Nucleic Acid Nanotechnology Revenue and Gross Margin (US$ Million) & (2021-2026) Table 79. Creative Biolabs Nucleic Acid Nanotechnology Product Portfolio Table 80. Creative Biolabs Recent Development Table 81. tilibit nanosystems Company Information Table 82. tilibit nanosystems Business Overview Table 83. tilibit nanosystems Nucleic Acid Nanotechnology Revenue and Gross Margin (US$ Million) & (2021-2026) Table 84. tilibit nanosystems Nucleic Acid Nanotechnology Product Portfolio Table 85. tilibit nanosystems Recent Development Table 86. North America Nucleic Acid Nanotechnology Revenue by Type (2021-2026) & (US$ Million) Table 87. North America Nucleic Acid Nanotechnology Revenue by Type (2027-2032) & (US$ Million) Table 88. North America Nucleic Acid Nanotechnology Revenue by Application (2021-2026) & (US$ Million) Table 89. North America Nucleic Acid Nanotechnology Revenue by Application (2027-2032) & (US$ Million) Table 90. North America Nucleic Acid Nanotechnology Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 91. North America Nucleic Acid Nanotechnology Revenue by Country (2021-2026) & (US$ Million) Table 92. North America Nucleic Acid Nanotechnology Revenue by Country (US$ Million) & (2027-2032) Table 93. Europe Nucleic Acid Nanotechnology Revenue by Type (2021-2026) & (US$ Million) Table 94. Europe Nucleic Acid Nanotechnology Revenue by Type (2027-2032) & (US$ Million) Table 95. Europe Nucleic Acid Nanotechnology Revenue by Application (2021-2026) & (US$ Million) Table 96. Europe Nucleic Acid Nanotechnology Revenue by Application (2027-2032) & (US$ Million) Table 97. Europe Nucleic Acid Nanotechnology Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 98. Europe Nucleic Acid Nanotechnology Revenue by Country (2021-2026) & (US$ Million) Table 99. Europe Nucleic Acid Nanotechnology Revenue by Country (US$ Million) & (2027-2032) Table 100. China Nucleic Acid Nanotechnology Revenue by Type (2021-2026) & (US$ Million) Table 101. China Nucleic Acid Nanotechnology Revenue by Type (2027-2032) & (US$ Million) Table 102. China Nucleic Acid Nanotechnology Revenue by Application (2021-2026) & (US$ Million) Table 103. China Nucleic Acid Nanotechnology Revenue by Application (2027-2032) & (US$ Million) Table 104. Asia Nucleic Acid Nanotechnology Revenue by Type (2021-2026) & (US$ Million) Table 105. Asia Nucleic Acid Nanotechnology Revenue by Type (2027-2032) & (US$ Million) Table 106. Asia Nucleic Acid Nanotechnology Revenue by Application (2021-2026) & (US$ Million) Table 107. Asia Nucleic Acid Nanotechnology Revenue by Application (2027-2032) & (US$ Million) Table 108. Asia Nucleic Acid Nanotechnology Revenue by Region (2021 VS 2025 VS 2032) & (US$ Million) Table 109. Asia Nucleic Acid Nanotechnology Revenue by Region (US$ Million) & (2021-2026) Table 110. Asia Nucleic Acid Nanotechnology Revenue by Region (US$ Million) & (2027-2032) Table 111. SAMEA Nucleic Acid Nanotechnology Revenue by Type (2021-2026) & (US$ Million) Table 112. SAMEA Nucleic Acid Nanotechnology Revenue by Type (2027-2032) & (US$ Million) Table 113. SAMEA Nucleic Acid Nanotechnology Revenue by Application (2021-2026) & (US$ Million) Table 114. SAMEA Nucleic Acid Nanotechnology Revenue by Application (2027-2032) & (US$ Million) Table 115. SAMEA Nucleic Acid Nanotechnology Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 116. SAMEA Nucleic Acid Nanotechnology Revenue by Country (2021-2026) & (US$ Million) Table 117. SAMEA Nucleic Acid Nanotechnology Revenue by Country (US$ Million) & (2027-2032) Table 118. Research Programs/Design for This Report Table 119. Authors List of This Report Table 120. Secondary Sources Table 121. Primary Sources List of Figures Figure 1. Nucleic Acid Nanotechnology Image Figure 2. Global Nucleic Acid Nanotechnology Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Nucleic Acid Nanotechnology Market Size Share 2021 VS 2025 VS 2032 Figure 4. DNA Nanotechnology Image Figure 5. RNA Nanotechnology Image Figure 6. Global Nucleic Acid Nanotechnology Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 7. Global Nucleic Acid Nanotechnology Market Size Share 2021 VS 2025 VS 2032 Figure 8. Drug Delivery Systems Image Figure 9. Biosensors Image Figure 10. Nanorobotics Image Figure 11. Other Image Figure 12. Global Nucleic Acid Nanotechnology Market Size (US$ Million) & (2021-2032) Figure 13. Global Nucleic Acid Nanotechnology Market Size, (US$ Million), 2021 VS 2025 VS 2032 Figure 14. Global Nucleic Acid Nanotechnology Market Share by Region: 2021 VS 2025 VS 2032 Figure 15. Global Nucleic Acid Nanotechnology Players Revenue Share Top 10 and Top 5 in 2025 Figure 16. Players Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 17. Global Nucleic Acid Nanotechnology Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 18. Global Nucleic Acid Nanotechnology Revenue Market Share 2021 VS 2025 VS 2032 Figure 19. Global Nucleic Acid Nanotechnology Revenue Market Share by Type (2021-2032) Figure 20. Global Nucleic Acid Nanotechnology Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 21. Global Nucleic Acid Nanotechnology Revenue Market Share by Application (2021 VS 2025 VS 2032) Figure 22. Global Nucleic Acid Nanotechnology Revenue Market Share by Application (2021-2032) Figure 23. North America Nucleic Acid Nanotechnology Revenue YoY Growth (2021-2032) & (US$ Million) Figure 24. North America Nucleic Acid Nanotechnology Revenue Share by Type (2021-2032) Figure 25. North America Nucleic Acid Nanotechnology Revenue Share by Application (2021-2032) Figure 26. North America Nucleic Acid Nanotechnology Revenue Share by Country (2021-2032) Figure 27. United States Nucleic Acid Nanotechnology Revenue YoY Growth (US$ Million) & (2021-2032) Figure 28. Canada Nucleic Acid Nanotechnology Revenue YoY Growth (US$ Million) & (2021-2032) Figure 29. Mexico Nucleic Acid Nanotechnology Revenue YoY Growth (US$ Million) & (2021-2032) Figure 30. Europe Nucleic Acid Nanotechnology Revenue YoY Growth (2021-2032) & (US$ Million) Figure 31. Europe Nucleic Acid Nanotechnology Revenue Share by Type (2021-2032) Figure 32. Europe Nucleic Acid Nanotechnology Revenue Share by Application (2021-2032) Figure 33. Europe Nucleic Acid Nanotechnology Revenue Share by Country (2021-2032) Figure 34. Germany Nucleic Acid Nanotechnology Revenue YoY Growth (US$ Million) & (2021-2032) Figure 35. France Nucleic Acid Nanotechnology Revenue YoY Growth (US$ Million) & (2021-2032) Figure 36. U.K. Nucleic Acid Nanotechnology Revenue YoY Growth (US$ Million) & (2021-2032) Figure 37. Italy Nucleic Acid Nanotechnology Revenue YoY Growth (US$ Million) & (2021-2032) Figure 38. Spain Nucleic Acid Nanotechnology Revenue YoY Growth (US$ Million) & (2021-2032) Figure 39. Russia Nucleic Acid Nanotechnology Revenue YoY Growth (US$ Million) & (2021-2032) Figure 40. Netherlands Nucleic Acid Nanotechnology Revenue YoY Growth (US$ Million) & (2021-2032) Figure 41. Nordic Countries Nucleic Acid Nanotechnology Revenue YoY Growth (US$ Million) & (2021-2032) Figure 42. China Nucleic Acid Nanotechnology Revenue YoY Growth (2021-2032) & (US$ Million) Figure 43. China Nucleic Acid Nanotechnology Revenue Share by Type (2021-2032) Figure 44. China Nucleic Acid Nanotechnology Revenue Share by Application (2021-2032) Figure 45. Asia Nucleic Acid Nanotechnology Revenue YoY Growth (2021-2032) & (US$ Million) Figure 46. Asia Nucleic Acid Nanotechnology Revenue Share by Type (2021-2032) Figure 47. Asia Nucleic Acid Nanotechnology Revenue Share by Application (2021-2032) Figure 48. Asia Nucleic Acid Nanotechnology Revenue Share by Region (2021-2032) Figure 49. Japan Nucleic Acid Nanotechnology Revenue YoY Growth (US$ Million) & (2021-2032) Figure 50. South Korea Nucleic Acid Nanotechnology Revenue YoY Growth (US$ Million) & (2021-2032) Figure 51. India Nucleic Acid Nanotechnology Revenue YoY Growth (US$ Million) & (2021-2032) Figure 52. Australia Nucleic Acid Nanotechnology Revenue YoY Growth (US$ Million) & (2021-2032) Figure 53. Taiwan Nucleic Acid Nanotechnology Revenue YoY Growth (US$ Million) & (2021-2032) Figure 54. Southeast Asia Nucleic Acid Nanotechnology Revenue YoY Growth (US$ Million) & (2021-2032) Figure 55. SAMEA Nucleic Acid Nanotechnology Revenue YoY Growth (2021-2032) & (US$ Million) Figure 56. SAMEA Nucleic Acid Nanotechnology Revenue Share by Type (2021-2032) Figure 57. SAMEA Nucleic Acid Nanotechnology Revenue Share by Application (2021-2032) Figure 58. SAMEA Nucleic Acid Nanotechnology Revenue Share by Country (2021-2032) Figure 59. Brazil Nucleic Acid Nanotechnology Revenue YoY Growth (US$ Million) & (2021-2032) Figure 60. Argentina Nucleic Acid Nanotechnology Revenue YoY Growth (US$ Million) & (2021-2032) Figure 61. Chile Nucleic Acid Nanotechnology Revenue YoY Growth (US$ Million) & (2021-2032) Figure 62. Colombia Nucleic Acid Nanotechnology Revenue YoY Growth (US$ Million) & (2021-2032) Figure 63. Peru Nucleic Acid Nanotechnology Revenue YoY Growth (US$ Million) & (2021-2032) Figure 64. Saudi Arabia Nucleic Acid Nanotechnology Revenue YoY Growth (US$ Million) & (2021-2032) Figure 65. Israel Nucleic Acid Nanotechnology Revenue YoY Growth (US$ Million) & (2021-2032) Figure 66. UAE Nucleic Acid Nanotechnology Revenue YoY Growth (US$ Million) & (2021-2032) Figure 67. Turkey Nucleic Acid Nanotechnology Revenue YoY Growth (US$ Million) & (2021-2032) Figure 68. Iran Nucleic Acid Nanotechnology Revenue YoY Growth (US$ Million) & (2021-2032) Figure 69. Egypt Nucleic Acid Nanotechnology Revenue YoY Growth (US$ Million) & (2021-2032) Figure 70. Years Considered Figure 71. Research Process Figure 72. Key Executives Interviewed

Scope & coverage.

Types
  • DNA Nanotechnology
  • RNA Nanotechnology
Applications
  • Drug Delivery Systems
  • Biosensors
  • Nanorobotics
  • Other
Companies covered
  • GATTAQUANT GMBH
  • NuProbe
  • Genisphere
  • Nanovery
  • Esya Labs
  • Nomic,
  • Torus Biosystems
  • NanoApps Medical, Inc.
  • Creative Biolabs
  • tilibit nanosystems

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Nucleic Acid Nanotechnology Market by Type
  3. 1.2.1 Global Nucleic Acid Nanotechnology Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 DNA Nanotechnology
  5. 1.2.3 RNA Nanotechnology
  6. 1.3 Nucleic Acid Nanotechnology Market by Application
  7. 1.3.1 Global Nucleic Acid Nanotechnology Market Size by Application, 2021 VS 2025 VS 2032
  8. 1.3.2 Drug Delivery Systems
  9. 1.3.3 Biosensors
  10. 1.3.4 Nanorobotics
  11. 1.3.5 Other
  12. 1.4 Assumptions and Limitations
  13. 1.5 Study Goals and Objectives
2 Nucleic Acid Nanotechnology Market Dynamics
  1. 2.1 Nucleic Acid Nanotechnology Industry Trends
  2. 2.2 Nucleic Acid Nanotechnology Industry Drivers
  3. 2.3 Nucleic Acid Nanotechnology Industry Opportunities and Challenges
  4. 2.4 Nucleic Acid Nanotechnology Industry Restraints
3 Global Growth Perspective
  1. 3.1 Global Nucleic Acid Nanotechnology Market Perspective (2021-2032)
  2. 3.2 Global Nucleic Acid Nanotechnology Growth Trends by Region
  3. 3.2.1 Global Nucleic Acid Nanotechnology Market Size by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Nucleic Acid Nanotechnology Market Size by Region (2021-2026)
  5. 3.2.3 Global Nucleic Acid Nanotechnology Market Size by Region (2027-2032)
4 Competitive Landscape by Players
  1. 4.1 Global Nucleic Acid Nanotechnology Revenue by Players
  2. 4.1.1 Global Nucleic Acid Nanotechnology Revenue by Players (2021-2026)
  3. 4.1.2 Global Nucleic Acid Nanotechnology Revenue Market Share by Players (2021-2026)
  4. 4.1.3 Global Nucleic Acid Nanotechnology Players Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Nucleic Acid Nanotechnology Key Players Ranking, 2024 VS 2025 VS 2026
  6. 4.3 Global Nucleic Acid Nanotechnology Key Players Headquarters & Area Served
  7. 4.4 Global Nucleic Acid Nanotechnology Players, Product Type & Application
  8. 4.5 Global Nucleic Acid Nanotechnology Players Establishment Date
  9. 4.6 Market Competitive Analysis
  10. 4.6.1 Global Nucleic Acid Nanotechnology Market CR5 and HHI
  11. 4.6.3 2025 Nucleic Acid Nanotechnology Tier 1, Tier 2, and Tier 3
5 Nucleic Acid Nanotechnology Market Size by Type
  1. 5.1 Global Nucleic Acid Nanotechnology Revenue by Type (2021 VS 2025 VS 2032)
  2. 5.2 Global Nucleic Acid Nanotechnology Revenue by Type (2021-2032)
  3. 5.3 Global Nucleic Acid Nanotechnology Revenue Market Share by Type (2021-2032)
6 Nucleic Acid Nanotechnology Market Size by Application
  1. 6.1 Global Nucleic Acid Nanotechnology Revenue by Application (2021 VS 2025 VS 2032)
  2. 6.2 Global Nucleic Acid Nanotechnology Revenue by Application (2021-2032)
  3. 6.3 Global Nucleic Acid Nanotechnology Revenue Market Share by Application (2021-2032)
7 Company Profiles
  1. 7.1 GATTAQUANT GMBH
  2. 7.1.1 GATTAQUANT GMBH Company Information
  3. 7.1.2 GATTAQUANT GMBH Business Overview
  4. 7.1.3 GATTAQUANT GMBH Nucleic Acid Nanotechnology Revenue and Gross Margin (2021-2026)
  5. 7.1.4 GATTAQUANT GMBH Nucleic Acid Nanotechnology Product Portfolio
  6. 7.1.5 GATTAQUANT GMBH Recent Developments
  7. 7.2 NuProbe
  8. 7.2.1 NuProbe Company Information
  9. 7.2.2 NuProbe Business Overview
  10. 7.2.3 NuProbe Nucleic Acid Nanotechnology Revenue and Gross Margin (2021-2026)
  11. 7.2.4 NuProbe Nucleic Acid Nanotechnology Product Portfolio
  12. 7.2.5 NuProbe Recent Developments
  13. 7.3 Genisphere
  14. 7.3.1 Genisphere Company Information
  15. 7.3.2 Genisphere Business Overview
  16. 7.3.3 Genisphere Nucleic Acid Nanotechnology Revenue and Gross Margin (2021-2026)
  17. 7.3.4 Genisphere Nucleic Acid Nanotechnology Product Portfolio
  18. 7.3.5 Genisphere Recent Developments
  19. 7.4 Nanovery
  20. 7.4.1 Nanovery Company Information
  21. 7.4.2 Nanovery Business Overview
  22. 7.4.3 Nanovery Nucleic Acid Nanotechnology Revenue and Gross Margin (2021-2026)
  23. 7.4.4 Nanovery Nucleic Acid Nanotechnology Product Portfolio
  24. 7.4.5 Nanovery Recent Developments
  25. 7.5 Esya Labs
  26. 7.5.1 Esya Labs Company Information
  27. 7.5.2 Esya Labs Business Overview
  28. 7.5.3 Esya Labs Nucleic Acid Nanotechnology Revenue and Gross Margin (2021-2026)
  29. 7.5.4 Esya Labs Nucleic Acid Nanotechnology Product Portfolio
  30. 7.5.5 Esya Labs Recent Developments
  31. 7.6 Nomic,
  32. 7.6.1 Nomic, Company Information
  33. 7.6.2 Nomic, Business Overview
  34. 7.6.3 Nomic, Nucleic Acid Nanotechnology Revenue and Gross Margin (2021-2026)
  35. 7.6.4 Nomic, Nucleic Acid Nanotechnology Product Portfolio
  36. 7.6.5 Nomic, Recent Developments
  37. 7.7 Torus Biosystems
  38. 7.7.1 Torus Biosystems Company Information
  39. 7.7.2 Torus Biosystems Business Overview
  40. 7.7.3 Torus Biosystems Nucleic Acid Nanotechnology Revenue and Gross Margin (2021-2026)
  41. 7.7.4 Torus Biosystems Nucleic Acid Nanotechnology Product Portfolio
  42. 7.7.5 Torus Biosystems Recent Developments
  43. 7.8 NanoApps Medical, Inc.
  44. 7.8.1 NanoApps Medical, Inc. Company Information
  45. 7.8.2 NanoApps Medical, Inc. Business Overview
  46. 7.8.3 NanoApps Medical, Inc. Nucleic Acid Nanotechnology Revenue and Gross Margin (2021-2026)
  47. 7.8.4 NanoApps Medical, Inc. Nucleic Acid Nanotechnology Product Portfolio
  48. 7.8.5 NanoApps Medical, Inc. Recent Developments
  49. 7.9 Creative Biolabs
  50. 7.9.1 Creative Biolabs Company Information
  51. 7.9.2 Creative Biolabs Business Overview
  52. 7.9.3 Creative Biolabs Nucleic Acid Nanotechnology Revenue and Gross Margin (2021-2026)
  53. 7.9.4 Creative Biolabs Nucleic Acid Nanotechnology Product Portfolio
  54. 7.9.5 Creative Biolabs Recent Developments
  55. 7.10 tilibit nanosystems
  56. 7.10.1 tilibit nanosystems Company Information
  57. 7.10.2 tilibit nanosystems Business Overview
  58. 7.10.3 tilibit nanosystems Nucleic Acid Nanotechnology Revenue and Gross Margin (2021-2026)
  59. 7.10.4 tilibit nanosystems Nucleic Acid Nanotechnology Product Portfolio
  60. 7.10.5 tilibit nanosystems Recent Developments
8 North America
  1. 8.1 North America Nucleic Acid Nanotechnology Revenue (2021-2032)
  2. 8.2 North America Nucleic Acid Nanotechnology Revenue by Type (2021-2032)
  3. 8.2.1 North America Nucleic Acid Nanotechnology Revenue by Type (2021-2026)
  4. 8.2.2 North America Nucleic Acid Nanotechnology Revenue by Type (2027-2032)
  5. 8.3 North America Nucleic Acid Nanotechnology Revenue Share by Type (2021-2032)
  6. 8.4 North America Nucleic Acid Nanotechnology Revenue by Application (2021-2032)
  7. 8.4.1 North America Nucleic Acid Nanotechnology Revenue by Application (2021-2026)
  8. 8.4.2 North America Nucleic Acid Nanotechnology Revenue by Application (2027-2032)
  9. 8.5 North America Nucleic Acid Nanotechnology Revenue Share by Application (2021-2032)
  10. 8.6 North America Nucleic Acid Nanotechnology Revenue by Country
  11. 8.6.1 North America Nucleic Acid Nanotechnology Revenue by Country (2021 VS 2025 VS 2032)
  12. 8.6.2 North America Nucleic Acid Nanotechnology Revenue by Country (2021-2026)
  13. 8.6.3 North America Nucleic Acid Nanotechnology Revenue by Country (2027-2032)
  14. 8.6.4 United States
  15. 8.6.5 Canada
  16. 8.6.6 Mexico
9 Europe
  1. 9.1 Europe Nucleic Acid Nanotechnology Revenue (2021-2032)
  2. 9.2 Europe Nucleic Acid Nanotechnology Revenue by Type (2021-2032)
  3. 9.2.1 Europe Nucleic Acid Nanotechnology Revenue by Type (2021-2026)
  4. 9.2.2 Europe Nucleic Acid Nanotechnology Revenue by Type (2027-2032)
  5. 9.3 Europe Nucleic Acid Nanotechnology Revenue Share by Type (2021-2032)
  6. 9.4 Europe Nucleic Acid Nanotechnology Revenue by Application (2021-2032)
  7. 9.4.1 Europe Nucleic Acid Nanotechnology Revenue by Application (2021-2026)
  8. 9.4.2 Europe Nucleic Acid Nanotechnology Revenue by Application (2027-2032)
  9. 9.5 Europe Nucleic Acid Nanotechnology Revenue Share by Application (2021-2032)
  10. 9.6 Europe Nucleic Acid Nanotechnology Revenue by Country
  11. 9.6.1 Europe Nucleic Acid Nanotechnology Revenue by Country (2021 VS 2025 VS 2032)
  12. 9.6.2 Europe Nucleic Acid Nanotechnology Revenue by Country (2021-2026)
  13. 9.6.3 Europe Nucleic Acid Nanotechnology Revenue by Country (2027-2032)
  14. 9.6.4 Germany
  15. 9.6.5 France
  16. 9.6.6 U.K.
  17. 9.6.7 Italy
  18. 9.6.8 Russia
  19. 9.6.9 Spain
  20. 9.6.10 Netherlands
  21. 9.6.11 Switzerland
  22. 9.6.12 Sweden
  23. 9.6.13 Poland
10 China
  1. 10.1 China Nucleic Acid Nanotechnology Revenue (2021-2032)
  2. 10.2 China Nucleic Acid Nanotechnology Revenue by Type (2021-2032)
  3. 10.2.1 China Nucleic Acid Nanotechnology Revenue by Type (2021-2026)
  4. 10.2.2 China Nucleic Acid Nanotechnology Revenue by Type (2027-2032)
  5. 10.3 China Nucleic Acid Nanotechnology Revenue Share by Type (2021-2032)
  6. 10.4 China Nucleic Acid Nanotechnology Revenue by Application (2021-2032)
  7. 10.4.1 China Nucleic Acid Nanotechnology Revenue by Application (2021-2026)
  8. 10.4.2 China Nucleic Acid Nanotechnology Revenue by Application (2027-2032)
  9. 10.5 China Nucleic Acid Nanotechnology Revenue Share by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Nucleic Acid Nanotechnology Revenue (2021-2032)
  2. 11.2 Asia Nucleic Acid Nanotechnology Revenue by Type (2021-2032)
  3. 11.2.1 Asia Nucleic Acid Nanotechnology Revenue by Type (2021-2026)
  4. 11.2.2 Asia Nucleic Acid Nanotechnology Revenue by Type (2027-2032)
  5. 11.3 Asia Nucleic Acid Nanotechnology Revenue Share by Type (2021-2032)
  6. 11.4 Asia Nucleic Acid Nanotechnology Revenue by Application (2021-2032)
  7. 11.4.1 Asia Nucleic Acid Nanotechnology Revenue by Application (2021-2026)
  8. 11.4.2 Asia Nucleic Acid Nanotechnology Revenue by Application (2027-2032)
  9. 11.5 Asia Nucleic Acid Nanotechnology Revenue Share by Application (2021-2032)
  10. 11.6 Asia Nucleic Acid Nanotechnology Revenue by Country
  11. 11.6.1 Asia Nucleic Acid Nanotechnology Revenue by Country (2021 VS 2025 VS 2032)
  12. 11.6.2 Asia Nucleic Acid Nanotechnology Revenue by Country (2021-2026)
  13. 11.6.3 Asia Nucleic Acid Nanotechnology Revenue by Country (2027-2032)
  14. 11.6.4 Japan
  15. 11.6.5 South Korea
  16. 11.6.6 India
  17. 11.6.7 Australia
  18. 11.6.8 Taiwan
  19. 11.6.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Nucleic Acid Nanotechnology Revenue (2021-2032)
  2. 12.2 SAMEA Nucleic Acid Nanotechnology Revenue by Type (2021-2032)
  3. 12.2.1 SAMEA Nucleic Acid Nanotechnology Revenue by Type (2021-2026)
  4. 12.2.2 SAMEA Nucleic Acid Nanotechnology Revenue by Type (2027-2032)
  5. 12.3 SAMEA Nucleic Acid Nanotechnology Revenue Share by Type (2021-2032)
  6. 12.4 SAMEA Nucleic Acid Nanotechnology Revenue by Application (2021-2032)
  7. 12.4.1 SAMEA Nucleic Acid Nanotechnology Revenue by Application (2021-2026)
  8. 12.4.2 SAMEA Nucleic Acid Nanotechnology Revenue by Application (2027-2032)
  9. 12.5 SAMEA Nucleic Acid Nanotechnology Revenue Share by Application (2021-2032)
  10. 12.6 SAMEA Nucleic Acid Nanotechnology Revenue by Country
  11. 12.6.1 SAMEA Nucleic Acid Nanotechnology Revenue by Country (2021 VS 2025 VS 2032)
  12. 12.6.2 SAMEA Nucleic Acid Nanotechnology Revenue by Country (2021-2026)
  13. 12.6.3 SAMEA Nucleic Acid Nanotechnology Revenue by Country (2027-2032)
  14. 12.6.4 Brazil
  15. 12.6.5 Argentina
  16. 12.6.6 Chile
  17. 12.6.7 Colombia
  18. 12.6.8 Peru
  19. 12.6.9 Saudi Arabia
  20. 12.6.10 Israel
  21. 12.6.11 UAE
  22. 12.6.12 Turkey
  23. 12.6.13 Iran
  24. 12.6.14 Egypt
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst